Austar Lifesciences Limited
AULSF
$0.07
$0.0651,300.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.24M | -3.56M | -9.35M | -12.61M | -15.94M |
| Total Depreciation and Amortization | 6.60M | 6.45M | 6.28M | 5.92M | 5.58M |
| Total Amortization of Deferred Charges | 856.20K | 842.50K | 826.90K | 829.20K | 834.60K |
| Total Other Non-Cash Items | 714.40K | 11.65M | 22.55M | 20.19M | 17.75M |
| Change in Net Operating Assets | 3.35M | -6.98M | -17.30M | -17.30M | -17.30M |
| Cash from Operations | 13.76M | 8.40M | 3.01M | -2.96M | -9.06M |
| Capital Expenditure | -2.85M | -4.22M | -5.57M | -7.65M | -9.79M |
| Sale of Property, Plant, and Equipment | 279.70K | 1.00M | 1.73M | 880.10K | 25.00K |
| Cash Acquisitions | 393.00K | 197.00K | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.79M | 2.16M | 1.53M | 1.80M | 2.07M |
| Cash from Investing | 609.10K | -855.60K | -2.31M | -4.97M | -7.69M |
| Total Debt Issued | 303.14M | 336.22M | 369.30M | 405.83M | 442.36M |
| Total Debt Repaid | -387.56M | -365.96M | -344.36M | -308.06M | -271.76M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.90M | -16.55M | -16.20M | -19.85M | -23.49M |
| Cash from Financing | -14.08M | -6.45M | 1.19M | 10.93M | 20.85M |
| Foreign Exchange rate Adjustments | 157.00K | 105.30K | 53.40K | 36.80K | 20.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 439.30K | 1.20M | 1.94M | 3.03M | 4.12M |